A global pharma company specializing in orphan drugs for rare diseases improved customer experience at 50% lower costs by revamping Standard Response Letters (SRLs) across 5+ therapeutic areas with Indegene's help. Challenges stemmed from inconsistent SRL content due to multiple vendors, undefined writing approaches and styles, which degraded experiences, inflated costs, and delayed timelines. Indegene's innovative software centralized Medical Information operations, streamlined processes, and developed comprehensive content guides covering literature search, evidence hierarchy, and framing best practices. This ensured standardized, high-quality SRLs, enhancing satisfaction while slashing expenses.

Join for free to read